Elimination of diaminopeptidase activity in Pichia pastoris for therapeutic protein production
详细信息 查看全文
- 作者：Daniel Hopkins (1)
Sujatha Gomathinayagam (1)
Heather Lynaugh (1)
Terrance A. Stadheim (1)
Stephen R. Hamilton (1) - 关键词：Diaminopeptidase ; STE13 ; DAP2 ; P. pastoris ; Proteolysis ; Recombinant protein
- 刊名：Applied Microbiology and Biotechnology
- 出版年：2014
- 出版时间：March 2014
- 年：2014
- 卷：98
- 期：6
- 页码：2573-2583
- 全文大小：2,518 KB
- 参考文献：1. Betenbaugh MJ, Tomiya N, Narang S, Hsu JT, Lee YC (2004) Biosynthesis of human-type N-glycans in heterologous systems. Curr Opin Struct Biol 14:601鈥?06 CrossRef
2. Bobrowicz P, Davidson RC, Li H, Potgieter TI, Nett JH, Hamilton SR, Stadheim TA, Miele RG, Bobrowicz B, Mitchell T, Rausch S, Renfer E, Wildt S (2004) Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast / Pichia pastoris: production of complex humanized glycoproteins with terminal galactose. Glycobiology 14:757鈥?66 CrossRef
3. Choi BK, Bobrowicz P, Davidson RC, Hamilton SR, Kung DH, Li H, Miele RG, Nett JH, Wildt S, Gerngross TU (2003) Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast / Pichia pastoris. Proc Natl Acad Sci U S A 100:5022鈥?027 CrossRef
4. Choi BK, Warburton S, Lin H, Patel R, Boldogh I, Meehl M, d鈥橝njou M, Pon L, Stadheim TA, Sethuraman N (2012) Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in / Pichia pastoris. Appl Microbiol Biotechnol 95:671鈥?82 CrossRef
5. Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA (2008) Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 358:1109鈥?117 CrossRef
6. Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27:297鈥?06 CrossRef
7. Ghaderi D, Taylor RE, Padler-Karavani V, Diaz S, Varki A (2010) Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins. Nat Biotechnol 28:863鈥?67 CrossRef
8. Ghosalkar A, Sahai V, Srivastava A (2008) Secretory expression of interferon-alpha 2b in recombinant / Pichia pastoris using three different secretion signals. Protein Expr Purif 60:103鈥?09 CrossRef
9. Goldstein AL, McCusker JH (1999) Three new dominant drug resistance cassettes for gene disruption in / Saccharomyces cerevisiae. Yeast 15:1541鈥?553
10. Hamilton SR, Gerngross TU (2007) Glycosylation engineering in yeast: the advent of fully humanized yeast. Curr Opin Biotechnol 18:387鈥?92 CrossRef
11. Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, Mitchell T, Nett JH, Rausch S, Stadheim TA, Wischnewski H, Wildt S, Gerngross TU (2003) Production of complex human glycoproteins in yeast. Science 301:1244鈥?246 CrossRef
12. Hamilton SR, Davidson RC, Sethuraman N, Nett JH, Jiang Y, Rios S, Bobrowicz P, Stadheim TA, Li H, Choi BK, Hopkins D, Wischnewski H, Roser J, Mitchell T, Strawbridge RR, Hoopes J, Wildt S, Gerngross TU (2006) Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 313:1441鈥?443 CrossRef
13. Hamilton SR, Cook WJ, Gomathinayagam S, Burnina I, Bukowski J, Hopkins D, Schwartz S, Du M, Sharkey NJ, Bobrowicz P, Wildt S, Li H, Stadheim TA, Nett JH (2013) Production of sialylated O-linked glycans in / Pichia pastoris. Glycobiology 23:1192鈥?203 CrossRef
14. Higashi H, Naiki M, Matuo S, Okouchi K (1977) Antigen of 鈥渟erum sickness鈥?type of heterophile antibodies in human sera: identification as gangliosides with N-glycolylneuraminic acid. Biochem Biophys Res Commun 79:388鈥?95 CrossRef
15. Hokke CH, Bergwerff AA, Vandedem GWK, Vanoostrum J, Kamerling JP, Vliegenthart JFG (1990) Sialylated carbohydrate chains of recombinant human glycoproteins expressed in Chinese-hamster ovary cells contain traces of N-glycolylneuraminic acid. FEBS Lett 275:9鈥?4 CrossRef
16. Hong WJ, Petell JK, Swank D, Sanford J, Hixson DC, Doyle D (1989) Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels. Exp Cell Res 182:256鈥?66 CrossRef
17. Hopkins D, Gomathinayagam S, Rittenhour AM, Du M, Hoyt E, Karaveg K, Mitchell T, Nett JH, Sharkey NJ, Stadheim TA, Li H, Hamilton SR (2011) Elimination of beta-mannose glycan structures in / Pichia pastoris. Glycobiology 21:1616鈥?626 CrossRef
18. Julius D, Blair L, Brake A, Sprague G, Thorner J (1983) Yeast alpha factor is processed from a larger precursor polypeptide: the essential role of a membrane-bound dipeptidyl aminopeptidase. Cell 32:839鈥?52 CrossRef
19. Kumagai Y, Yajima A, Konishi K (2003) Peptidase activity of dipeptidyl aminopeptidase IV produced by / Porphyromonas gingivalis is important but not sufficient for virulence. Microbiol Immunol 47:735鈥?43 CrossRef
20. Maeng BH, Choi J, Sa YS, Shin JH, Kim YH (2012) Functional expression of recombinant anti-BNP scFv in methylotrophic yeast / Pichia pastoris and application as a recognition molecule in electrochemical sensors. World J Microbiol Biotechnol 28:1027鈥?034 CrossRef
21. Matoba S, Morano KA, Klionsky DJ, Kim K, Ogrydziak DM (1997) Dipeptidyl aminopeptidase processing and biosynthesis of alkaline extracellular protease from / Yarrowia lipolytica. Microbiology 143:3263鈥?272 CrossRef
22. Misumi Y, Hayashi Y, Arakawa F, Ikehara Y (1992) Molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface. Biochim Biophys Acta 1131:333鈥?36 CrossRef
23. Montrose-Rafizadeh C, Yang H, Rodgers BD, Beday A, Pritchette LA, Eng J (1997) High potency antagonists of the pancreatic glucagon-like peptide-1 receptor. J Biol Chem 272:21201鈥?1206 CrossRef
24. Nett JH, Gerngross TU (2003) Cloning and disruption of the PpURA5 gene and construction of a set of integration vectors for the stable genetic modification of / Pichia pastoris. Yeast 20:1279鈥?290
25. Prabha L, Govindappa N, Adhikary L, Melarkode R, Sastry K (2009) Identification of the dipeptidyl aminopeptidase responsible for N-terminal clipping of recombinant Exendin-4 precursor expressed in / Pichia pastoris. Protein Expr Purif 64:155鈥?61 CrossRef
26. Punt PJ, van Biezen N, Conesa A, Albers A, Mangnus J, van den Hondel C (2002) Filamentous fungi as cell factories for heterologous protein production. Trends Biotechnol 20:200鈥?06 CrossRef
27. Roberts CJ, Nothwehr SF, Stevens TH (1992) Membrane protein sorting in the yeast secretory pathway: evidence that the vacuole may be the default compartment. J Cell Biol 119:69鈥?3 CrossRef
28. Sethuraman N, Stadheim TA (2006) Challenges in therapeutic glycoprotein production. Curr Opin Biotechnol 17:341鈥?46 CrossRef
29. Suarez-Rendueles P, Wolf DH (1987) Identification of the structural gene for dipeptidyl aminopeptidase yscV (DAP2) of / Saccharomyces cerevisiae. J Bacteriol 169:4041鈥?048
30. Walsh G (2010) Biopharmaceutical benchmarks 2010. Nat Biotechnol 28:917鈥?24 CrossRef
31. Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30:1158鈥?170 CrossRef - 作者单位：Daniel Hopkins (1)
Sujatha Gomathinayagam (1)
Heather Lynaugh (1)
Terrance A. Stadheim (1)
Stephen R. Hamilton (1)
1. GlycoFi, Inc. (a wholly owned subsidiary of Merck & Co., Inc.), Biologics Discovery, Merck Research Laboratories, 16 Cavendish Court, Lebanon, NH, 03766, USA - ISSN：1432-0614
文摘
Yeast are important production platforms for the generation of recombinant proteins. Nonetheless, their use has been restricted in the production of therapeutic proteins due to differences in their glycosylation profile with that of higher eukaryotes. The yeast strain Pichia pastoris is an industrially important organism. Recent advances in the glycoengineering of this strain offer the potential to produce therapeutic glycoproteins with sialylated human-like N- and O-linked glycans. However, like higher eukaryotes, yeast also express numerous proteases, many of which are either localized to the secretory pathway or pass through it en route to their final destination. As a consequence, nondesirable proteolysis of some recombinant proteins may occur, with the specific cleavage being dependent on the class of protease involved. Dipeptidyl aminopeptidases (DPP) are a class of proteolytic enzymes which remove a two-amino acid peptide from the N-terminus of a protein. In P. pastoris, two such enzymes have been identified, Ste13p and Dap2p. In the current report, we demonstrate that while the knockout of STE13 alone may protect certain proteins from N-terminal clipping, other proteins may require the double knockout of both STE13 and DAP2. As such, this understanding of DPP activity enhances the utility of the P. pastoris expression system, thus facilitating the production of recombinant therapeutic proteins with their intact native sequences.